These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7257040)

  • 21. [Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
    Chen N; Gong J; Zeng H; Wei Q; Zhu YC; Chen M; Zhou Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):109-13. PubMed ID: 21355314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of bladder washing cytology in the diagnosis and follow-up of bladder tumors].
    Maier U
    Urol Int; 1983; 38(5):267-70. PubMed ID: 6636369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of 1-2-dimethylhydrazine-induced bowel carcinogenesis by the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Steele G; Chrissey M; Gittes R; Corson J; Wilson R
    Carcinogenesis; 1980 Feb; 1(2):135-8. PubMed ID: 22282992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of dimethylhydrazine bowel carcinogenesis in rats.
    Steele G; Crissey M; Gittes R; Harte P; Wilson R; Corson J
    Cancer; 1981 May; 47(9):2218-21. PubMed ID: 7226115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer.
    Wiener HG; Vooijs GP; van't Hof-Grootenboer B
    Acta Cytol; 1993; 37(2):163-9. PubMed ID: 8465635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive urinary cytology after tumor resection: an indicator for concomitant carcinoma in situ.
    Harving N; Wolf H; Melsen F
    J Urol; 1988 Sep; 140(3):495-7. PubMed ID: 3411659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinyl acetate prophylaxis in cancer of the urinary bladder.
    Dawson WD; Miller WW; Liles WB
    Invest Urol; 1979 Mar; 16(5):376-7. PubMed ID: 429134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
    Soloway MS; Martino C; Hyatt C; Marrone JC
    Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.
    Lekili M; Sener E; Demir MA; Temeltaş G; Müezzinoğlu T; Büyüksu C
    Urol Res; 2004 May; 32(2):124-8. PubMed ID: 14685796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractionated cystography to assess infiltration of the bladder wall by intravesical tumors.
    Sakkas JL; Kailis D; Pissidis AG
    Int Surg; 1975 May; 60(5):273-5. PubMed ID: 1126810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoma bladder: comparative evaluation of urinary cytology, excretory urography and ultrasonography.
    Ravi R; Rao RC; Ahlawat R; Berry M
    Indian J Cancer; 1990 Mar; 27(1):55-61. PubMed ID: 2202667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
    Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an in vitro and in vivo epithelial tumor model for the study of invasion.
    Pauli BU; Anderson SN; Memoli VA; Kuettner KE
    Cancer Res; 1980 Dec; 40(12):4571-80. PubMed ID: 7438091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Suprapubic bladder ultrasonography and urinary cytology: indications and limits in the follow-up of superficial bladder tumors].
    Pegoraro C; Bondavalli C; Molani L; Capitanio A; Schiavon L; Dall'Oglio B; Luciano M; Negri S
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63 Suppl 2():127-9. PubMed ID: 1836650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of P53 oncoprotein in urinary wash cytology: experience in patients with superficial bladder carcinoma].
    Moreno Sierra J; Luengo Alpuente S; López García-Asenjo J; Redondo González E; Blanco Jiménez E; Fernández Pérez C; Silmi Moyano A; Resel Estévez L
    Arch Esp Urol; 1999 Nov; 52(9):943-54. PubMed ID: 10633962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between a purified and standard diet on FANFT-induced murine bladder cancer.
    Soloway MS; Nissenkorn I; McCallum LW
    Urology; 1981 Nov; 18(5):482-4. PubMed ID: 7314340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urinary cytology in cases of bladder cancer: a critical evaluation].
    Rathert P
    Urologe A; 2003 Jul; 42(7):908-11. PubMed ID: 12898033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experiences based on the classification of bladder tumours according to the TNM system.
    Vogler H; Rothkopf M; Mebel M
    Eur Urol; 1975; 1(2):93-5. PubMed ID: 1233174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.